NCT03219450
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT03219450
NCT05100056
NCT07541391
NCT06458439
NCT06856226
NCT07609576
NCT07609030
NCT07052916
NCT07001384